首页 > 最新文献

ISRN cardiology最新文献

英文 中文
Comparison of 12-month outcomes with zotarolimus- and Paclitaxel-eluting stents: a meta-analysis. 佐他莫司和紫杉醇洗脱支架12个月疗效比较:荟萃分析
Pub Date : 2011-01-01 Epub Date: 2011-05-26 DOI: 10.5402/2011/675638
Rohit S Loomba, Suraj Chandrasekar, Neil Malhotra, Rohit R Arora

Revascularization after myocardial infarction is often achieved via percutaneous coronary intervention, which often entails stenting. Drug-eluting stents have shown benefits over bare metal stents in this setting, and a variety of drug-eluting stents are now available, including sirolimus-, paclitaxel-, and zotarolimus-eluting stents. There are studies that have compared the various drug-eluting stents and this meta-analysis pools data comparing 12-month clinical outcomes of zotarolimus- and paclitaxel-eluting stents. End points studied were myocardial infarction, major adverse cardiac events, cardiac death, all-cause death, stent thrombosis, target vessel revascularization, and target lesion revascularization.There was a statistically significant reduction in risk of myocardial infarction (odds ratio, 0.250, confidence interval, 0.160 to 0.392) and statistically insignificant reductions in major adverse cardiac events (odds ratio, 0.813, confidence interval, 0.656 to 1.007), cardiac death (odds ratio, 0.817, confidence interval, 0.359 to 1.857), all cause death (odds ratio, 0.820, confidence interval, 0.443 to 1.516), and target lesion revascularization (odds ratio, 0.936, confidence interval 0.702 to 1.247). There was a statistically significant increase in target vessel revascularization (odds ratio, 1.336, confidence interval, 1.003 to 1.778) and a statistically insignificant increase in stent thrombosis (odds ratio, 1.174, confidence interval, 0.604 to 2.280). These findings are similar to the individual studies although other studies have noted increased late loss with zotarolimus-eluting stents and this current data associated with late loss should be kept in mind when makimg clinical decisions regarding sent selection.

心肌梗死后的血运重建通常通过经皮冠状动脉介入治疗来实现,这通常需要支架植入术。在这种情况下,药物洗脱支架已经显示出比裸金属支架更好的效果,现在有多种药物洗脱支架可用,包括西罗莫司、紫杉醇和佐他莫司洗脱支架。有研究比较了各种药物洗脱支架,本荟萃分析汇集了比较佐他莫司和紫杉醇洗脱支架12个月临床结果的数据。研究的终点为心肌梗死、主要心脏不良事件、心源性死亡、全因死亡、支架血栓形成、靶血管重建术和靶病变重建术。心肌梗死的风险降低具有统计学意义(优势比为0.250,可信区间为0.160 ~ 0.392),主要心脏不良事件(优势比为0.813,可信区间为0.656 ~ 1.007)、心源性死亡(优势比为0.817,可信区间为0.359 ~ 1.857)、全因死亡(优势比为0.820,可信区间为0.443 ~ 1.516)和靶病变血流量重建术(优势比为0.936,可信区间为0.160 ~ 0.392)的降低无统计学意义。置信区间0.702至1.247)。靶血管重建术增加有统计学意义(优势比1.336,可信区间1.003 ~ 1.778),支架内血栓形成增加无统计学意义(优势比1.174,可信区间0.604 ~ 2.280)。这些发现与个别研究相似,尽管其他研究也注意到佐他莫司洗脱支架的后期损失增加,并且在做出关于移植选择的临床决策时应牢记与晚期损失相关的当前数据。
{"title":"Comparison of 12-month outcomes with zotarolimus- and Paclitaxel-eluting stents: a meta-analysis.","authors":"Rohit S Loomba,&nbsp;Suraj Chandrasekar,&nbsp;Neil Malhotra,&nbsp;Rohit R Arora","doi":"10.5402/2011/675638","DOIUrl":"https://doi.org/10.5402/2011/675638","url":null,"abstract":"<p><p>Revascularization after myocardial infarction is often achieved via percutaneous coronary intervention, which often entails stenting. Drug-eluting stents have shown benefits over bare metal stents in this setting, and a variety of drug-eluting stents are now available, including sirolimus-, paclitaxel-, and zotarolimus-eluting stents. There are studies that have compared the various drug-eluting stents and this meta-analysis pools data comparing 12-month clinical outcomes of zotarolimus- and paclitaxel-eluting stents. End points studied were myocardial infarction, major adverse cardiac events, cardiac death, all-cause death, stent thrombosis, target vessel revascularization, and target lesion revascularization.There was a statistically significant reduction in risk of myocardial infarction (odds ratio, 0.250, confidence interval, 0.160 to 0.392) and statistically insignificant reductions in major adverse cardiac events (odds ratio, 0.813, confidence interval, 0.656 to 1.007), cardiac death (odds ratio, 0.817, confidence interval, 0.359 to 1.857), all cause death (odds ratio, 0.820, confidence interval, 0.443 to 1.516), and target lesion revascularization (odds ratio, 0.936, confidence interval 0.702 to 1.247). There was a statistically significant increase in target vessel revascularization (odds ratio, 1.336, confidence interval, 1.003 to 1.778) and a statistically insignificant increase in stent thrombosis (odds ratio, 1.174, confidence interval, 0.604 to 2.280). These findings are similar to the individual studies although other studies have noted increased late loss with zotarolimus-eluting stents and this current data associated with late loss should be kept in mind when makimg clinical decisions regarding sent selection.</p>","PeriodicalId":73519,"journal":{"name":"ISRN cardiology","volume":"2011 ","pages":"675638"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262499/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30470822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of PPARα Intron 7 Polymorphism with Coronary Artery Disease: A Cross-Sectional Study. PPARα内含子7多态性与冠状动脉疾病的相关性:一项横断面研究
Pub Date : 2011-01-01 Epub Date: 2011-04-07 DOI: 10.5402/2011/816025
Sreeja Purushothaman, V K Ajitkumar, R Renuka Nair

The allelic variants of peroxisome proliferator-activated receptor alpha (PPARα) can influence the risk of coronary artery disease (CAD) by virtue of its effect on lipid metabolism. However, the role of PPARα intronic polymorphism with CAD has received little attention. The association of allelic variants G/C at intron 7 of the PPAR-alpha gene with CAD was examined in a hospital-based Indian population. PPAR genotyping was performed in 110 male patients with CAD and 120 age and ethnically matched healthy males by PCR amplification of the gene followed by restriction digestion. Presence of C allele showed a positive association with CAD (OR = 2.9; 95% CI [1.65-4.145]; P = .009) and also with dyslipidaemia (OR = 2.95, 95% CI (1.5-4.39); P < .05). Impaired lipid metabolism in carriers of the PPARα Intron 7C allele is possibly responsible for the predilection to CAD.

过氧化物酶体增殖物激活受体α (PPARα)的等位基因变异可通过影响脂质代谢而影响冠状动脉疾病(CAD)的风险。然而,PPARα内含子多态性在CAD中的作用很少受到关注。ppar - α基因内含子7的等位变异G/C与CAD的关系在医院的印度人群中进行了检查。对110例CAD男性患者和120例年龄和种族匹配的健康男性进行了PPAR基因分型,方法是PCR扩增该基因,然后限制性消化。C等位基因的存在与CAD呈正相关(OR = 2.9;95% ci [1.65-4.145];P = 0.009),同时伴有血脂异常(OR = 2.95, 95% CI (1.5-4.39);P < 0.05)。PPARα内含子7C等位基因携带者的脂质代谢受损可能是CAD易感性的原因。
{"title":"Association of PPARα Intron 7 Polymorphism with Coronary Artery Disease: A Cross-Sectional Study.","authors":"Sreeja Purushothaman,&nbsp;V K Ajitkumar,&nbsp;R Renuka Nair","doi":"10.5402/2011/816025","DOIUrl":"https://doi.org/10.5402/2011/816025","url":null,"abstract":"<p><p>The allelic variants of peroxisome proliferator-activated receptor alpha (PPARα) can influence the risk of coronary artery disease (CAD) by virtue of its effect on lipid metabolism. However, the role of PPARα intronic polymorphism with CAD has received little attention. The association of allelic variants G/C at intron 7 of the PPAR-alpha gene with CAD was examined in a hospital-based Indian population. PPAR genotyping was performed in 110 male patients with CAD and 120 age and ethnically matched healthy males by PCR amplification of the gene followed by restriction digestion. Presence of C allele showed a positive association with CAD (OR = 2.9; 95% CI [1.65-4.145]; P = .009) and also with dyslipidaemia (OR = 2.95, 95% CI (1.5-4.39); P < .05). Impaired lipid metabolism in carriers of the PPARα Intron 7C allele is possibly responsible for the predilection to CAD.</p>","PeriodicalId":73519,"journal":{"name":"ISRN cardiology","volume":"2011 ","pages":"816025"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/816025","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30471336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Estimation of absolute cardiovascular risk in individuals with diabetes mellitus: rationale and approaches. 估计糖尿病患者的绝对心血管风险:基本原理和方法。
Pub Date : 2011-01-01 Epub Date: 2011-11-23 DOI: 10.5402/2011/242656
Justin B Echouffo-Tcheugui, Modele O Ogunniyi, André P Kengne
Purpose. To examine the usefulness of cardiovascular risk estimation models in people with diabetes. Methods. Review of published studies that compare the discriminative power of major cardiovascular risk factors single or in combination in individuals with and without diabetes, for major cardiovascular outcomes. Results. In individuals with and without diabetes, major risk factors affect cardiovascular risk similarly, with no evidence of any significant interaction. Accounting for diabetes-specific parameters, cardiopreventative therapies can significantly improve risk estimation in diabetes. General and diabetes-specific cardiovascular risk models have a useful discriminative power, but tend to overestimate risk in individuals with diabetes. Their impact on care delivery, adherence to therapies, and patients' outcome remain poorly understood. Conclusions. The high-risk status conferred by diabetes does not preclude the estimation of absolute cardiovascular risk estimation using global risk tools in individuals with diabetes, as this is useful for the initiation and intensification of preventive measures.
目的。目的:探讨糖尿病患者心血管风险评估模型的有效性。方法。对已发表的比较糖尿病患者和非糖尿病患者主要心血管危险因素单一或组合的鉴别能力的研究进行综述。结果。在患有和不患有糖尿病的个体中,主要危险因素对心血管风险的影响相似,没有证据表明有任何显著的相互作用。考虑到糖尿病的特定参数,心脏预防治疗可以显著改善糖尿病的风险估计。一般和糖尿病特异性心血管风险模型具有有用的判别能力,但往往高估糖尿病患者的风险。它们对护理提供、治疗依从性和患者预后的影响仍然知之甚少。结论。糖尿病所赋予的高风险状态并不排除使用全球风险工具对糖尿病患者进行绝对心血管风险估计,因为这对于启动和加强预防措施是有用的。
{"title":"Estimation of absolute cardiovascular risk in individuals with diabetes mellitus: rationale and approaches.","authors":"Justin B Echouffo-Tcheugui,&nbsp;Modele O Ogunniyi,&nbsp;André P Kengne","doi":"10.5402/2011/242656","DOIUrl":"https://doi.org/10.5402/2011/242656","url":null,"abstract":"Purpose. To examine the usefulness of cardiovascular risk estimation models in people with diabetes. Methods. Review of published studies that compare the discriminative power of major cardiovascular risk factors single or in combination in individuals with and without diabetes, for major cardiovascular outcomes. Results. In individuals with and without diabetes, major risk factors affect cardiovascular risk similarly, with no evidence of any significant interaction. Accounting for diabetes-specific parameters, cardiopreventative therapies can significantly improve risk estimation in diabetes. General and diabetes-specific cardiovascular risk models have a useful discriminative power, but tend to overestimate risk in individuals with diabetes. Their impact on care delivery, adherence to therapies, and patients' outcome remain poorly understood. Conclusions. The high-risk status conferred by diabetes does not preclude the estimation of absolute cardiovascular risk estimation using global risk tools in individuals with diabetes, as this is useful for the initiation and intensification of preventive measures.","PeriodicalId":73519,"journal":{"name":"ISRN cardiology","volume":"2011 ","pages":"242656"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262525/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30472046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Genetic Polymorphisms as Risk Stratification Tool in Primary Preventive ICD Therapy. 遗传多态性作为初级预防ICD治疗的风险分层工具。
Pub Date : 2011-01-01 Epub Date: 2011-04-18 DOI: 10.5402/2011/457247
Roman Laszlo, Mathias C Busch, Jüergen Schreieck

More and more implantable cardioverter-defibrillators (ICDs) are implanted as primary prevention of sudden cardiac death (SCD). However, major problem in practice is to identify high-risk patients for SCD. Different methods for noninvasive risk stratification do not have a sufficient positive or negative predictive value. Since current approaches lead to implantation of ICDs in a large number of patients who will never suffer an arrhythmic event and simultaneously patients still die of SCD who currently did not seem eligible for primary preventive ICD implantation, there is a need for additional tools for risk stratification. Epidemiological studies point to a hereditary risk of SCD. Different susceptibility of each person concerning arrhythmogenic events might be explained by genetic polymorphisms. By obtaining an individual "pattern" of polymorphisms of genes encoding for proteins which are important in arrhythmogenesis in one patient, risk stratification in primary prevention of SCD might by improved.

植入式心律转复除颤器(ICDs)作为心脏性猝死(SCD)的一级预防手段被越来越多地植入。然而,在实践中主要的问题是识别SCD的高危患者。不同的无创风险分层方法没有足够的阳性或阴性预测值。由于目前的方法导致大量从未发生过心律失常事件的患者植入ICD,同时仍有患者死于SCD,目前似乎不符合初级预防性ICD植入的条件,因此需要额外的风险分层工具。流行病学研究指出SCD有遗传风险。每个人对心律失常事件的不同易感性可以用遗传多态性来解释。通过获得单个患者心律失常发生中重要的蛋白质编码基因多态性的个体“模式”,可以改善SCD一级预防的风险分层。
{"title":"Genetic Polymorphisms as Risk Stratification Tool in Primary Preventive ICD Therapy.","authors":"Roman Laszlo,&nbsp;Mathias C Busch,&nbsp;Jüergen Schreieck","doi":"10.5402/2011/457247","DOIUrl":"https://doi.org/10.5402/2011/457247","url":null,"abstract":"<p><p>More and more implantable cardioverter-defibrillators (ICDs) are implanted as primary prevention of sudden cardiac death (SCD). However, major problem in practice is to identify high-risk patients for SCD. Different methods for noninvasive risk stratification do not have a sufficient positive or negative predictive value. Since current approaches lead to implantation of ICDs in a large number of patients who will never suffer an arrhythmic event and simultaneously patients still die of SCD who currently did not seem eligible for primary preventive ICD implantation, there is a need for additional tools for risk stratification. Epidemiological studies point to a hereditary risk of SCD. Different susceptibility of each person concerning arrhythmogenic events might be explained by genetic polymorphisms. By obtaining an individual \"pattern\" of polymorphisms of genes encoding for proteins which are important in arrhythmogenesis in one patient, risk stratification in primary prevention of SCD might by improved.</p>","PeriodicalId":73519,"journal":{"name":"ISRN cardiology","volume":"2011 ","pages":"457247"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/457247","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30472053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Surgical treatment in active infective endocarditis: results of a four-year experience. 活动性感染性心内膜炎的手术治疗:四年经验的结果。
Pub Date : 2011-01-01 Epub Date: 2011-05-18 DOI: 10.5402/2011/492543
Carlo Rostagno, Enrico Carone, Alessandra Rossi, Gian Franco Gensini, Pier Luigi Stefano

Background. Aim of present investigation was to analyze survival and recurrence rate in patients with active endocarditis referred to our centre for surgical treatment. Methods. 80 consecutive patients with active infective endocarditis (52 males, 28 females, mean age 59.2 years) were referred to our institution for surgical treatment. 78 patients underwent surgery, and 2 patients died before intervention. Results. Fifty patients had native valve endocarditis, 30 prosthetic valve involvement. Hospital mortality has been 10.2%. Three discharged patients (4.9%) died at an average 18-month followup. Endocarditis recurred in 4 (2 being S. aureus prosthetic tricuspid endocarditis in drug addicts). All patients who underwent valve repair or homograft implant were alive and free of recurrence. Conclusions. Our results suggest that with proper surgical treatment patients with active endocarditis discharged alive from hospital have a survival >90% at 18 months with a low recurrence rate.

背景。本研究的目的是分析到我中心行手术治疗的活动性心内膜炎患者的生存率和复发率。方法:连续80例活动性感染性心内膜炎患者(男52例,女28例,平均年龄59.2岁)转诊至我院接受手术治疗。78例患者接受手术治疗,2例患者在干预前死亡。结果。50例患者有先天性瓣膜心内膜炎,30例人工瓣膜受累。住院死亡率为10.2%。3例出院患者(4.9%)在平均18个月的随访中死亡。4例复发心内膜炎(2例为金黄色葡萄球菌假体三尖瓣性心内膜炎)。所有接受瓣膜修复或同种异体移植的患者均存活且无复发。结论。我们的研究结果表明,通过适当的手术治疗,活动性心内膜炎患者出院后18个月生存率>90%,复发率低。
{"title":"Surgical treatment in active infective endocarditis: results of a four-year experience.","authors":"Carlo Rostagno,&nbsp;Enrico Carone,&nbsp;Alessandra Rossi,&nbsp;Gian Franco Gensini,&nbsp;Pier Luigi Stefano","doi":"10.5402/2011/492543","DOIUrl":"https://doi.org/10.5402/2011/492543","url":null,"abstract":"<p><p>Background. Aim of present investigation was to analyze survival and recurrence rate in patients with active endocarditis referred to our centre for surgical treatment. Methods. 80 consecutive patients with active infective endocarditis (52 males, 28 females, mean age 59.2 years) were referred to our institution for surgical treatment. 78 patients underwent surgery, and 2 patients died before intervention. Results. Fifty patients had native valve endocarditis, 30 prosthetic valve involvement. Hospital mortality has been 10.2%. Three discharged patients (4.9%) died at an average 18-month followup. Endocarditis recurred in 4 (2 being S. aureus prosthetic tricuspid endocarditis in drug addicts). All patients who underwent valve repair or homograft implant were alive and free of recurrence. Conclusions. Our results suggest that with proper surgical treatment patients with active endocarditis discharged alive from hospital have a survival >90% at 18 months with a low recurrence rate.</p>","PeriodicalId":73519,"journal":{"name":"ISRN cardiology","volume":"2011 ","pages":"492543"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/492543","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30470817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Coronary artery perforation and regrowth of a side branch occluded by a polytetrafluoroethylene-covered stent implantation. 冠状动脉穿孔和侧支再生闭塞聚四氟乙烯支架植入。
Pub Date : 2011-01-01 Epub Date: 2011-04-26 DOI: 10.5402/2011/212851
Shams Y-Hassan, Christer Sylvén, Loghman Henareh

Stenting of the right coronary artery stenosis caused coronary perforation and profound dye (blood) extravasation in a 69-year-old female patient. Instantaneous balloon inflation followed by implantation of a polytetrafluoroethylene- (PTFE-)covered stent sealed the coronary perforation, restored the blood flow, and perceivably caused acute occlusion of a large side branch (SB). The immediate in situ balloon inflation prevented the development of cardiac tamponade. Surprisingly, followup coronary angiography 4 and 11 months later showed spontaneous recanalization of the SB occluded by PTFE-covered stent. The SB was filled through a channel beginning at the end of the covered stent streaming retrogradely beneath it toward the SB ostium. Up to the best of our knowledge, this is the first described case of late spontaneous recanalization of as SB occluded by a PTFE-covered stent.

右冠状动脉狭窄支架置入导致冠状动脉穿孔和深染(血)外渗。瞬时球囊充气后植入聚四氟乙烯(PTFE)覆盖支架,封闭冠状动脉穿孔,恢复血流,并明显引起大侧支(SB)的急性闭塞。立即原位球囊膨胀防止了心脏填塞的发展。令人惊讶的是,4个月和11个月后的冠状动脉造影显示被ptfe覆盖的支架闭塞的SB自发再通。从覆盖支架末端开始的通道向SB口逆行流动,填充SB。据我们所知,这是第一例被聚四氟乙烯覆盖的支架闭塞的晚期自发性血管再通的病例。
{"title":"Coronary artery perforation and regrowth of a side branch occluded by a polytetrafluoroethylene-covered stent implantation.","authors":"Shams Y-Hassan,&nbsp;Christer Sylvén,&nbsp;Loghman Henareh","doi":"10.5402/2011/212851","DOIUrl":"https://doi.org/10.5402/2011/212851","url":null,"abstract":"<p><p>Stenting of the right coronary artery stenosis caused coronary perforation and profound dye (blood) extravasation in a 69-year-old female patient. Instantaneous balloon inflation followed by implantation of a polytetrafluoroethylene- (PTFE-)covered stent sealed the coronary perforation, restored the blood flow, and perceivably caused acute occlusion of a large side branch (SB). The immediate in situ balloon inflation prevented the development of cardiac tamponade. Surprisingly, followup coronary angiography 4 and 11 months later showed spontaneous recanalization of the SB occluded by PTFE-covered stent. The SB was filled through a channel beginning at the end of the covered stent streaming retrogradely beneath it toward the SB ostium. Up to the best of our knowledge, this is the first described case of late spontaneous recanalization of as SB occluded by a PTFE-covered stent.</p>","PeriodicalId":73519,"journal":{"name":"ISRN cardiology","volume":"2011 ","pages":"212851"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/212851","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30471030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between Younger Age, Autoimmunity, Cardiometabolic Risk, Oxidative Stress, HAART, and Ischemic Stroke in Africans with HIV/AIDS. 非洲艾滋病毒/艾滋病患者的年龄、自身免疫、心脏代谢风险、氧化应激、HAART 和缺血性中风之间的关系。
Pub Date : 2011-01-01 Epub Date: 2011-05-23 DOI: 10.5402/2011/897908
Benjamin Longo-Mbenza, Murielle Longokolo Mashi, Michel Lelo Tshikwela, Etienne Mokondjimobe, Thierry Gombet, Bertrand Ellenga-Mbolla, Augustin Nge Okwe, Nelly Kangola Kabangu, Simon Mbungu Fuele

Background and Purpose. It now appears clear that both HIV/AIDS and antiretroviral therapy (HAART) use are associated with higher risk of cardiovascular disease such as stroke. In this study, we evaluated the prevalence, the risk factors, and the cardiometabolic comorbidities of stroke in HIV/AIDS Central African patients. Methods. This hospital-based cross-sectional study collected clinical, laboratory, and imaging data of black Central African heterosexual, intravenous drug nonuser, and HIV/AIDS patients. Results. There were 54 men and 62 women, with a female to male ratio of 1.2 : 1. All were defined by hypercoagulability and oxidative stress. Hemorrhagic stroke was reported in 1 patient, ischemic stroke in 17 patients, and all stroke subtypes in 18 patients (15%). Younger age <45 years (P = .003), autoimmunity (P < .0001), and metabolic syndrome defined by IDF criteria (P < .0001) were associated with ischemic stroke. Conclusions. Clustering of several cardiometabolic factors, autoimmunity, oxidative stress, and lifestyle changes may explain accelerated atherosclerosis and high risk of stroke in these young black Africans with HIV/AIDS. Prevention and intervention programs are needed.

背景与目的。目前看来,艾滋病毒/艾滋病和抗逆转录病毒疗法(HAART)的使用与中风等心血管疾病的高风险相关。在这项研究中,我们评估了中非艾滋病患者中风的患病率、风险因素和心脏代谢合并症。研究方法这项以医院为基础的横断面研究收集了中非黑人异性恋者、非静脉注射吸毒者和艾滋病患者的临床、实验室和影像学数据。结果。其中男性 54 人,女性 62 人,男女比例为 1.2:1。所有患者都存在高凝状态和氧化应激。出血性中风 1 例,缺血性中风 17 例,所有中风亚型 18 例(15%)。年龄较小
{"title":"Relationship between Younger Age, Autoimmunity, Cardiometabolic Risk, Oxidative Stress, HAART, and Ischemic Stroke in Africans with HIV/AIDS.","authors":"Benjamin Longo-Mbenza, Murielle Longokolo Mashi, Michel Lelo Tshikwela, Etienne Mokondjimobe, Thierry Gombet, Bertrand Ellenga-Mbolla, Augustin Nge Okwe, Nelly Kangola Kabangu, Simon Mbungu Fuele","doi":"10.5402/2011/897908","DOIUrl":"10.5402/2011/897908","url":null,"abstract":"<p><p>Background and Purpose. It now appears clear that both HIV/AIDS and antiretroviral therapy (HAART) use are associated with higher risk of cardiovascular disease such as stroke. In this study, we evaluated the prevalence, the risk factors, and the cardiometabolic comorbidities of stroke in HIV/AIDS Central African patients. Methods. This hospital-based cross-sectional study collected clinical, laboratory, and imaging data of black Central African heterosexual, intravenous drug nonuser, and HIV/AIDS patients. Results. There were 54 men and 62 women, with a female to male ratio of 1.2 : 1. All were defined by hypercoagulability and oxidative stress. Hemorrhagic stroke was reported in 1 patient, ischemic stroke in 17 patients, and all stroke subtypes in 18 patients (15%). Younger age <45 years (P = .003), autoimmunity (P < .0001), and metabolic syndrome defined by IDF criteria (P < .0001) were associated with ischemic stroke. Conclusions. Clustering of several cardiometabolic factors, autoimmunity, oxidative stress, and lifestyle changes may explain accelerated atherosclerosis and high risk of stroke in these young black Africans with HIV/AIDS. Prevention and intervention programs are needed.</p>","PeriodicalId":73519,"journal":{"name":"ISRN cardiology","volume":"2011 ","pages":"897908"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262512/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30471291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of some common food constituents on cardiovascular disease. 一些常见食物成分对心血管疾病的影响。
Pub Date : 2011-01-01 Epub Date: 2011-06-16 DOI: 10.5402/2011/397136
Yaling Yang, Sze Wa Chan, Miao Hu, Richard Walden, Brian Tomlinson

Cardiovascular diseases are the major cause of morbidity and mortality worldwide, and there is considerable interest in the role of dietary constituents and supplements in the prevention and treatment of these disorders. We reviewed the major publications related to potential effects on cardiovascular risk factors and outcomes of some common dietary constituents: carotenoids, flavonoid-rich cocoa, tea, red wine and grapes, coffee, omega-3 fatty acids, and garlic. Increased intake of some of these has been associated with reduced all-cause mortality or reduced incidence of myocardial infraction, stroke, and hypertension. However, although the evidence from observational studies is supportive of beneficial effects for most of these foodstuffs taken as part of the diet, potential benefits from the use of supplements derived from these natural products remain largely inconclusive.

心血管疾病是世界范围内发病率和死亡率的主要原因,人们对膳食成分和补充剂在预防和治疗这些疾病中的作用非常感兴趣。我们回顾了一些常见膳食成分对心血管危险因素和结果的潜在影响的主要出版物:类胡萝卜素、富含类黄酮的可可、茶、红酒和葡萄、咖啡、omega-3脂肪酸和大蒜。其中一些的摄入量增加与降低全因死亡率或降低心肌梗死、中风和高血压的发病率有关。然而,尽管来自观察性研究的证据支持将这些食品作为饮食的一部分对大多数人有益,但使用这些天然产品衍生的补充剂的潜在益处在很大程度上仍不确定。
{"title":"Effects of some common food constituents on cardiovascular disease.","authors":"Yaling Yang,&nbsp;Sze Wa Chan,&nbsp;Miao Hu,&nbsp;Richard Walden,&nbsp;Brian Tomlinson","doi":"10.5402/2011/397136","DOIUrl":"https://doi.org/10.5402/2011/397136","url":null,"abstract":"<p><p>Cardiovascular diseases are the major cause of morbidity and mortality worldwide, and there is considerable interest in the role of dietary constituents and supplements in the prevention and treatment of these disorders. We reviewed the major publications related to potential effects on cardiovascular risk factors and outcomes of some common dietary constituents: carotenoids, flavonoid-rich cocoa, tea, red wine and grapes, coffee, omega-3 fatty acids, and garlic. Increased intake of some of these has been associated with reduced all-cause mortality or reduced incidence of myocardial infraction, stroke, and hypertension. However, although the evidence from observational studies is supportive of beneficial effects for most of these foodstuffs taken as part of the diet, potential benefits from the use of supplements derived from these natural products remain largely inconclusive.</p>","PeriodicalId":73519,"journal":{"name":"ISRN cardiology","volume":"2011 ","pages":"397136"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/397136","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30470816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 35
Short-term effects of ketamine and isoflurane on left ventricular ejection fraction in an experimental Swine model. 氯胺酮和异氟醚对实验性猪左心室射血分数的短期影响。
Pub Date : 2011-01-01 Epub Date: 2011-06-27 DOI: 10.5402/2011/582658
Benjamin Wessler, Christopher Madias, Natesa Pandian, Mark S Link

Background. General anesthesia is an essential element of experimental medical procedures. Ketamine and isoflurane are agents commonly used to induce and maintain anesthesia in animals. The cardiovascular effects of these anesthetic agents are diverse, and the response of global myocardial function is unknown. Methods. In a series of 15 swine, echocardiography measurements of left ventricular ejection fraction (LVEF) were obtained before the animals received anesthesia (baseline), after an intramuscular injection of ketamine (postketamine) and after inhaled isoflurane (postisoflurane). Results. The mean LVEF of an unanesthetized swine was 47 ± 3%. There was a significant decrease in the mean LVEF after administration of ketamine to 41 + 6.5% (P = 0.003). The addition of inhaled isoflurane did not result in further decrease in mean LVEF (mean LVEF 38 ± 7.2%, P = 0.22). Eight of the swine had an increase in their LVEF with sympathetic stimulation. Conclusions. In our experimental model the administration of ketamine was associated with decreased LV function. The decrease may be largely secondary to a blunting of sympathetic tone. The addition of isoflurane to ketamine did not significantly change LV function. A significant number of animals had returned to preanesthesia LV function with sympathetic stimulation.

背景。全身麻醉是实验性医疗程序的基本要素。氯胺酮和异氟醚是常用来诱导和维持动物麻醉的药物。这些麻醉药对心血管的影响是多种多样的,对整体心肌功能的反应尚不清楚。方法。在15头猪中,在动物接受麻醉前(基线)、肌内注射氯胺酮后(氯胺酮后)和吸入异氟醚后(异氟醚后)获得左心室射血分数(LVEF)的超声心动图测量。结果。未麻醉猪的平均LVEF为47±3%。给予氯胺酮后平均LVEF显著降低至41 + 6.5% (P = 0.003)。吸入异氟醚未导致平均LVEF进一步降低(平均LVEF 38±7.2%,P = 0.22)。其中八头猪在交感神经刺激下LVEF增加。结论。在我们的实验模型中,氯胺酮的使用与左室功能下降有关。这种减少可能主要是由于交感神经的钝化。氯胺酮中加入异氟醚对左室功能无显著影响。大量动物在交感刺激下恢复了麻醉前左室功能。
{"title":"Short-term effects of ketamine and isoflurane on left ventricular ejection fraction in an experimental Swine model.","authors":"Benjamin Wessler,&nbsp;Christopher Madias,&nbsp;Natesa Pandian,&nbsp;Mark S Link","doi":"10.5402/2011/582658","DOIUrl":"https://doi.org/10.5402/2011/582658","url":null,"abstract":"<p><p>Background. General anesthesia is an essential element of experimental medical procedures. Ketamine and isoflurane are agents commonly used to induce and maintain anesthesia in animals. The cardiovascular effects of these anesthetic agents are diverse, and the response of global myocardial function is unknown. Methods. In a series of 15 swine, echocardiography measurements of left ventricular ejection fraction (LVEF) were obtained before the animals received anesthesia (baseline), after an intramuscular injection of ketamine (postketamine) and after inhaled isoflurane (postisoflurane). Results. The mean LVEF of an unanesthetized swine was 47 ± 3%. There was a significant decrease in the mean LVEF after administration of ketamine to 41 + 6.5% (P = 0.003). The addition of inhaled isoflurane did not result in further decrease in mean LVEF (mean LVEF 38 ± 7.2%, P = 0.22). Eight of the swine had an increase in their LVEF with sympathetic stimulation. Conclusions. In our experimental model the administration of ketamine was associated with decreased LV function. The decrease may be largely secondary to a blunting of sympathetic tone. The addition of isoflurane to ketamine did not significantly change LV function. A significant number of animals had returned to preanesthesia LV function with sympathetic stimulation.</p>","PeriodicalId":73519,"journal":{"name":"ISRN cardiology","volume":"2011 ","pages":"582658"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/582658","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30470818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
Survival after drowning with cardiac arrest and mild hypothermia. 溺水后心脏骤停和轻度体温过低的存活。
Pub Date : 2011-01-01 Epub Date: 2011-04-26 DOI: 10.5402/2011/895625
S S Rudolph, S Barnung

The current guidelines for resucitation following hypothermia and submersion with cardiac arrest state that rewarming should be continued until a core temperature of 32-34°C is achieved, after which death can be declared if no return of spontaneous circulation has occurred. As no randomized, controlled trials exist, these treatment guidelines are mostly based on a pragmatic approach. Wheater to start or stop resuscitation is notoriusly difficult. Submersion time, water temperature, and prompt resuscitation seem to be crucial factors for outcome. We report a case of successful resuscitation after the use of mechanical chest compressions and extracorporeal circulation in a patient with cardiac arrest due to submersion and accompanying mild hypothermia with a core temperature of 32,2°C caused by submersion.

目前的低温和心脏骤停浸泡后复苏指南规定,应继续恢复体温,直到核心温度达到32-34°C,在此之后,如果没有发生自发循环的恢复,则可以宣布死亡。由于没有随机对照试验存在,这些治疗指南大多基于实用的方法。开始或停止复苏是出了名的困难。浸泡时间、水温和及时复苏似乎是影响结果的关键因素。我们报告了一例在使用机械胸部按压和体外循环后成功复苏的病例,该患者因溺水而导致心脏骤停,并伴有轻度低温,核心温度为32,2°C。
{"title":"Survival after drowning with cardiac arrest and mild hypothermia.","authors":"S S Rudolph,&nbsp;S Barnung","doi":"10.5402/2011/895625","DOIUrl":"https://doi.org/10.5402/2011/895625","url":null,"abstract":"<p><p>The current guidelines for resucitation following hypothermia and submersion with cardiac arrest state that rewarming should be continued until a core temperature of 32-34°C is achieved, after which death can be declared if no return of spontaneous circulation has occurred. As no randomized, controlled trials exist, these treatment guidelines are mostly based on a pragmatic approach. Wheater to start or stop resuscitation is notoriusly difficult. Submersion time, water temperature, and prompt resuscitation seem to be crucial factors for outcome. We report a case of successful resuscitation after the use of mechanical chest compressions and extracorporeal circulation in a patient with cardiac arrest due to submersion and accompanying mild hypothermia with a core temperature of 32,2°C caused by submersion.</p>","PeriodicalId":73519,"journal":{"name":"ISRN cardiology","volume":"2011 ","pages":"895625"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/895625","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30471290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
期刊
ISRN cardiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1